BDTX Black Diamond Therapeutics, Inc
$1.98▲ +1.02%
Healthcare
Other
After hours
$2.00▲ +1.01%
Sep 11, 7:40 PM ET
Volume 588.1K
Avg Volume (10D) 531.8K
Key Metrics & Fundamentals
Market Cap
$113.46M
P/E Ratio
–
Div Yield
–%
52W Range
1.60 - 4.94
% vs 50 MA
0.57%
% vs 200 MA
-16.11%
RSI-14
44.2
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.81
Free Cash Flow
-$7.97M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$12.03M
COGS
–
Operating Exp
$12.06M
Operating Income
-$12.06M
EBIT
-$12.06M
Pretax Income
-$9.91M
Net Income
-$9.91M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
Black Diamond (BDTX) Up 9.4% Since Last Earnings Report: Can It Continue?
Zacks · Sep 4, 2026 3:30 PM
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 2, 2026 8:01 PM
Black Diamond: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 8:55 PM
Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 5, 2026 8:01 PM
Financial Overview - Income Statement
Quarterly
Mar 2025
See BDTX's money flow as a full page
Social Sentiment
Avg +0.75 · 2 posts
DDNewsDiscussionBDTX - Why I’m all in on this stock
r/investing · May 5, 2025
The author is expressing enthusiasm and highlighting positive developments like drug trials and a sale.
positive
+0.80
NewsDiscussionTradePriceTargetDDBDTX - diamond in the rough
r/investing · Apr 1, 2025
The post highlights positive aspects like a licensing deal, Phase 2 development, and a significant market cap, indicating optimism.
positive
+0.70
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.